Cargando…

Age-Dependent Dysregulation of Muscle Vasculature and Blood Flow Recovery after Hindlimb Ischemia in the mdx Model of Duchenne Muscular Dystrophy

Duchenne muscular dystrophy (DMD), caused by a lack of functional dystrophin, is characterized by progressive muscle degeneration. Interestingly, dystrophin is also expressed in endothelial cells (ECs), and insufficient angiogenesis has already been hypothesized to contribute to DMD pathology, howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Podkalicka, Paulina, Mucha, Olga, Kaziród, Katarzyna, Bronisz-Budzyńska, Iwona, Ostrowska-Paton, Sophie, Tomczyk, Mateusz, Andrysiak, Kalina, Stępniewski, Jacek, Dulak, Józef, Łoboda, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145677/ https://www.ncbi.nlm.nih.gov/pubmed/33925757 http://dx.doi.org/10.3390/biomedicines9050481

Ejemplares similares

miR-378 affects metabolic disturbances in the mdx model of Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2022)

Simvastatin does not alleviate muscle pathology in a mouse model of Duchenne muscular dystrophy
por: Mucha, Olga, et al.
Publicado: (2021)

miR-146a deficiency does not aggravate muscular dystrophy in mdx mice
por: Bronisz-Budzyńska, Iwona, et al.
Publicado: (2019)

Targeting angiogenesis in Duchenne muscular dystrophy
por: Podkalicka, Paulina, et al.
Publicado: (2019)

Dysregulated Autophagy and Mitophagy in a Mouse Model of Duchenne Muscular Dystrophy Remain Unchanged Following Heme Oxygenase-1 Knockout
por: Mucha, Olga, et al.
Publicado: (2021)

Lack of miR-378 attenuates muscular dystrophy in mdx mice
por: Podkalicka, Paulina, et al.
Publicado: (2020)

Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
por: Kaziród, Katarzyna, et al.
Publicado: (2022)

Effect of heme oxygenase-1 on the differentiation of human myoblasts and the regeneration of murine skeletal muscles after acute and chronic injury
por: Głowniak-Kwitek, Urszula, et al.
Publicado: (2023)

Proteome Profiling of the Dystrophic mdx Mice Diaphragm
por: Mucha, Olga, et al.
Publicado: (2023)

Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
por: Łoboda, Agnieszka, et al.
Publicado: (2020)

The role of Nrf2 in acute and chronic muscle injury
por: Bronisz-Budzyńska, Iwona, et al.
Publicado: (2020)

Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes
por: Podkalicka, Paulina, et al.
Publicado: (2020)

Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research
por: Andrysiak, Kalina, et al.
Publicado: (2021)

Hypoxia as a Driving Force of Pluripotent Stem Cell Reprogramming and Differentiation to Endothelial Cells
por: Podkalicka, Paulina, et al.
Publicado: (2020)

The multifaceted view of heart problem in Duchenne muscular dystrophy
por: Florczyk-Soluch, Urszula, et al.
Publicado: (2021)

Social stress is lethal in the mdx model of Duchenne muscular dystrophy
por: Razzoli, Maria, et al.
Publicado: (2020)

Heme oxygenase inhibition in cancers: possible tools and targets
por: Podkalicka, Paulina, et al.
Publicado: (2018)

miR-378 influences muscle satellite cells and enhances adipogenic potential of fibro-adipogenic progenitors but does not affect muscle regeneration in the glycerol-induced injury model
por: Mucha, Olga, et al.
Publicado: (2023)

Ventilatory Chemosensory Drive Is Blunted in the mdx Mouse Model of Duchenne Muscular Dystrophy (DMD)
por: Mosqueira, Matias, et al.
Publicado: (2013)

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy
por: Miglietta, Daniela, et al.
Publicado: (2015)

Comparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients
por: Hyzewicz, Janek, et al.
Publicado: (2015)

Natural disease history of the D2-mdx mouse model for Duchenne muscular dystrophy
por: van Putten, Maaike, et al.
Publicado: (2019)

In vivo cerebellar circuit function is disrupted in an mdx mouse model of Duchenne muscular dystrophy
por: Stay, Trace L., et al.
Publicado: (2019)

Emotional behavior and brain anatomy of the mdx52 mouse model of Duchenne muscular dystrophy
por: Saoudi, Amel, et al.
Publicado: (2021)

A Novel Method for Detecting Duchenne Muscular Dystrophy in Blood Serum of mdx Mice
por: Ralbovsky, Nicole M., et al.
Publicado: (2022)

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle
por: Lorena, Marcelo dos Santos Voltani, et al.
Publicado: (2023)

Biomarkers for Duchenne muscular dystrophy progression: impact of age in the mdx tongue spared muscle
por: Lorena, Marcelo dos Santos Voltani, et al.
Publicado: (2023)

Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective
por: Donen, Graham, et al.
Publicado: (2023)

Variability in Cardiac miRNA-122 Level Determines Therapeutic Potential of miRNA-Regulated AAV Vectors
por: Kraszewska, Izabela, et al.
Publicado: (2020)

Revertant Fibers in the mdx Murine Model of Duchenne Muscular Dystrophy: An Age- and Muscle-Related Reappraisal
por: Pigozzo, Sarah R., et al.
Publicado: (2013)

Dystropathology Increases Energy Expenditure and Protein Turnover in the Mdx Mouse Model of Duchenne Muscular Dystrophy
por: Radley-Crabb, Hannah G., et al.
Publicado: (2014)

Disease course in mdx:utrophin(+/−) mice: comparison of three mouse models of Duchenne muscular dystrophy
por: McDonald, Abby A, et al.
Publicado: (2015)

The Effect of Vitamin D Supplementation on Skeletal Muscle in the mdx Mouse Model of Duchenne Muscular Dystrophy
por: Debruin, Danielle A., et al.
Publicado: (2019)

Myelination is delayed during postnatal brain development in the mdx mouse model of Duchenne muscular dystrophy
por: Aranmolate, Azeez, et al.
Publicado: (2017)

Cardiovascular phenotype of the Dmd(mdx) rat – a suitable animal model for Duchenne muscular dystrophy
por: Szabó, Petra Lujza, et al.
Publicado: (2021)

Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy
por: Ponzetti, Marco, et al.
Publicado: (2022)

Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy
por: Boccanegra, Brigida, et al.
Publicado: (2023)

RANKL Inhibition Reduces Cardiac Hypertrophy in mdx Mice and Possibly in Children with Duchenne Muscular Dystrophy
por: Marcadet, Laetitia, et al.
Publicado: (2023)

NRF2 Regulates Viability, Proliferation, Resistance to Oxidative Stress, and Differentiation of Murine Myoblasts and Muscle Satellite Cells
por: Bronisz-Budzyńska, Iwona, et al.
Publicado: (2022)

Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, in Contrast to Adipose Tissue-Derived Stromal Cells, Efficiently Improve Heart Function in Murine Model of Myocardial Infarction
por: Stępniewski, Jacek, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dc45in4jrhbvt66la6dilntbkk